Showing 1581-1590 of 20878 results for "".
- Innovative Nanoformulations: Overcoming Chemotherapy Resistancehttps://reachmd.com/news/nanoformulations-chemotherapy-resistance/2484667/Paclitaxel–pterostilbene nanoparticles markedly increase paclitaxel solubility and antitumor activity, offering a direct translational route to overcome taxane resistance by enabling higher intratumoral delivery with less reliance on solvent excipients. Current paclitaxel formulation
- Nutritional Interventions Impact on Maternal and Childhood Anemia in Sindh, Pakistanhttps://reachmd.com/news/nutritional-interventions-impact-on-maternal-and-childhood-anemia-in-sindh-pakistan/2484643/Lady Health Worker (LHW)–led community delivery of a wheat–soya blend plus targeted lipid-based or micronutrient powders produced a large program-level decline in maternal anemia, with immediate implications for prenatal and postpartum care. The finding also highlights persistent co
- Road Exposure After ICD Implantation: Implications for Crash Risk Assessmenthttps://reachmd.com/news/road-exposure-after-icd-implantation-implications-for-crash-risk-assessment/2484647/Recipients of implantable cardioverter-defibrillators sharply reduce driving after implantation — a behavioral shift that can mask true crash risk if analyses ignore exposure.
- Responding to Infant Infectious Threats: Pertussis and Botulismhttps://reachmd.com/news/responding-to-infant-infectious-threats-pertussis-and-botulism/2484662/Pertussis and infant botulism are concurrently escalating threats to young infants
- SCRATCH-AD: Rapid-Onset Anti-Itch and Anti-Inflammatory Effects of Ruxolitinib Creamhttps://reachmd.com/news/scratch-ad-rapid-onset-anti-itch-and-anti-inflammatory-effects-of-ruxolitinib-cream/2484591/Results from the SCRATCH-AD study suggested that ruxolitinib cream 1.5% provided itch relief, as well as broader improvements in atopic dermatitis (AD) severity The SCRATCH-AD study evaluated how quickly ruxolitinib 1.5% cream
- Regeneron Showcases Innovative Oncology Advances at ASHhttps://reachmd.com/news/regeneron-showcases-innovative-oncology-advances-at-ash/2484613/Regeneron presented a broad suite of hematology abstracts at ASH that directly inform treatment options across multiple blood cancers and rare hematologic disorders. The company is highlighting bispecific antibodies, costimulatory bispecifics, and a monoclonal antib
- The Emerging Impact of Digital Habits on Mental Health: A Clinical Perspectivehttps://reachmd.com/news/the-emerging-impact-of-digital-habits-on-mental-health-a-clinical-perspective/2484649/A one-week, structured reduction in social media use produced measurable short‑term improvements in young adults’ mental health. The study fou
- Expanded Non-Invasive Prenatal Testing in Thailand: Clinical Insightshttps://reachmd.com/news/expanded-non-invasive-prenatal-testing-in-thailand-clinical-insights/2484660/Expanded non-invasive prenatal testing (NIPT) implemented in routine prenatal care in Thailand accurately detects common chromosomal abnormalities and materially influences pregnancy outcomes. This large-scale implementation clarifies real-world performance in a middle-income settin
- Assessing the Impact of Environmental Exposures on Respiratory Health: Clinical Insightshttps://reachmd.com/news/assessing-the-impact-of-environmental-exposures-on-respiratory-health-clinical-insights/2484650/Large Danish nurses cohort links long-term black carbon exposure with higher incidence of asthma and COPD, even after accounting fo
- Translocation of Hospital-Acquired Pathogens: Implications for Sepsis and Resistancehttps://reachmd.com/news/translocation-of-hospital-acquired-pathogens-implications-for-sepsis-and-resistance/2484641/Pseudomonas aeruginosa demonstrates a documented lung-to-gut movement, creating a gut reservoir that raises immediate sepsis risk in vulnerable inpatients. That within-patient transloc